PSY8 Bipolar disorder

Descripción

(Psychiatry) PHCY320 Test sobre PSY8 Bipolar disorder, creado por Mer Scott el 13/10/2019.
Mer Scott
Test por Mer Scott, actualizado hace más de 1 año
Mer Scott
Creado por Mer Scott hace alrededor de 5 años
4
0

Resumen del Recurso

Pregunta 1

Pregunta
Bipolar epidemiology • Lifetime prevalence of bipolar disorder is ~4.5% • 1% of patients meeting criteria for [blank_start]bipolar I[blank_end], 1.1% for [blank_start]bipolar II[blank_end], and 2.4% of patients with [blank_start]subthreshold bipolar disorder[blank_end] (i.e., cyclothymia, unspecified bipolar disorder) • Symptom onset for depression, mania, or hypomania in bipolar disorder typically occurs in [blank_start]late adolescence or early adulthood[blank_end], with >⅔ of those affected developing symptoms before [blank_start]18[blank_end] years • Depression and mixed presentations may occur more frequently in [blank_start]women[blank_end] • Neuroimaging indicates that several anatomic regions (primarily the [blank_start]amygdala[blank_end] within the limbic system and the [blank_start]prefrontal[blank_end] cortex) may contribute to functional abnormalities in bipolar patients • Research suggests that altered [blank_start]synaptic and circuit[blank_end] functioning accounts for mood and cognitive changes seen in bipolar disorder, rather than dysfunction of individual neurotransmitters • Fluctuating severity of episodes mean its up to an average of [blank_start]8[blank_end] years before mood stabilisers are used
Respuesta
  • bipolar I
  • bipolar II
  • subthreshold bipolar disorder
  • late adolescence or early adulthood
  • 18
  • women
  • amygdala
  • prefrontal
  • synaptic and circuit
  • 8

Pregunta 2

Pregunta
4 types of mood episodes: 1. Manic episode - abnormally elevated [blank_start]arousal, affect, and energy[blank_end] level. Inflated [blank_start]self-esteem[blank_end], racing [blank_start]thoughts[blank_end], talking [blank_start]quickly[blank_end], [blank_start]sleep[blank_end] difficulty, engages in [blank_start]risky[blank_end] behaviors. A manic episode is differed from hypomania by [blank_start]hospital admission[blank_end]. 2. Major depressive episode - low [blank_start]mood[blank_end], anhedonia, apathy, etc. 3. Hypomania - elevated or [blank_start]irritated[blank_end] mood, usually a [blank_start]shorter[blank_end] duration than mania. 4. Mixed - meets criteria for [blank_start]both[blank_end] manic and depressive episode Sub-syndromal manic or depressive episodes might also occur which might not meet diagnostic criteria for one of these episodes.
Respuesta
  • arousal, affect, and energy
  • self-esteem
  • thoughts
  • quickly
  • sleep
  • risky
  • hospital admission
  • mood
  • irritated
  • shorter
  • both

Pregunta 3

Pregunta
• Bipolar Type I - occurrence of at least one [blank_start]manic or mixed[blank_end] (full mania and full depression simultaneously) episode. Typically experience major depressive episodes as well. • Bipolar Type II – [blank_start]hypomanic and depressive[blank_end] episodes.
Respuesta
  • manic or mixed
  • hypomanic and depressive

Pregunta 4

Pregunta
Others: Cyclothymic disorder - Chronic fluctuations between [blank_start]subsyndromal[blank_end] depressive and hypomanic episodes (2 years for adults and 1 year for children and adolescents) Persistent depressive disorder ([blank_start]Dysthymia[blank_end]) - Depressed mood most days for at least [blank_start]2[blank_end] years (1 year in children and adolescents). [blank_start]Unspecified[blank_end] bipolar and related disorder - Mood states do not meet [blank_start]full[blank_end] criteria
Respuesta
  • subsyndromal
  • 2
  • Dysthymia
  • Unspecified
  • full

Pregunta 5

Pregunta
Alcohol and substance abuse is common (up to 50% of bipolar patients) and has a significant impact on the age of onset, course of illness and response to treatment.
Respuesta
  • True
  • False

Pregunta 6

Pregunta
5 - 15% of Bipolar II patients will develop a manic episode over a 5-year period. If this happens the diagnosis is changed to bipolar I disorder.
Respuesta
  • True
  • False

Pregunta 7

Pregunta
Choose the incorrect statement.
Respuesta
  • About half of bipolar I patients have some degree of functional disability after onset, and ~ 10 - 20% have severely impaired psycho-social and occupational functioning.
  • Suicide attempts occur in up to 50% of patients with bipolar disorder
  • Approximately 10 - 19% of people with bipolar I disorder commit suicide
  • Medication discontinuation occurs in 20 - 60% of patients secondary to multiple factors
  • Rapid cycling (>4 mood episodes/year) is more common in men and occurs in ~10 - 20% of bipolar I and II disorder patients making their prognosis poor

Pregunta 8

Pregunta
Bipolar as a spectrum: - Type ½ - ‘Schizobipolar’ disorder: [blank_start]Positive symptoms of psychosis[blank_end] with manic, hypomanic, and depressive episodes - Type 1 ½ - [blank_start]prolonged hypomania without depression[blank_end], at risk for bipolar type II - Type 2 ½ - [blank_start]cyclothymia[blank_end] with full [blank_start]depressive[blank_end] episode(s) - Type III – [blank_start]antidepressant induced hypomania[blank_end] - Type III ½ - bipolar type 1 with [blank_start]substance abuse-induced hypomania[blank_end]
Respuesta
  • Positive symptoms of psychosis
  • prolonged hypomania without depression
  • cyclothymia
  • depressive
  • antidepressant induced hypomania
  • substance abuse-induced hypomania

Pregunta 9

Pregunta
• An ideal “mood stabilizer” would treat both mania and depression whilst preventing episodes of either pole, but there is as yet [blank_start]no[blank_end] evidence to suggest that any [blank_start]single[blank_end] agent can consistently achieve this • Different [blank_start]drugs[blank_end]/classes effective for different [blank_start]phases[blank_end] of bipolar disorder • Antidepressants either do not work, or may worsen symptoms for some (bipolar [blank_start]1[blank_end]) by de-stabilising mood and inducing mania or hypomania, [blank_start]rapid cycling[blank_end] or mixed states and possibly suicidality
Respuesta
  • no
  • single
  • drugs
  • phases
  • rapid cycling
  • 1

Pregunta 10

Pregunta
Drug Txs: 1. Lithium Narrow therapeutic range and renal toxicity therefore [blank_start]TDM[blank_end] needed, range 0.6 - 0.75 mmol/L. Wide variation in dose required, initially [blank_start]0.4–1.2 g[blank_end] daily od or bd. 80% reduced risk of [blank_start]suicide[blank_end], possibly by decreasing impulsive-aggressive behavior. Possible MoAs: modulates [blank_start]G[blank_end] proteins, affects [blank_start]signal[blank_end] transduction via inhibition of [blank_start]2nd messenger enzymes[blank_end], interferes with [blank_start]downstream[blank_end] signal transduction cascades. 2. Valproic acid Effective for the [blank_start]manic[blank_end] phase of bipolar disorder and may prevent recurrence. Not an established treatment for preventing depression but effective for some. MoA: interferes with voltage-sensitive [blank_start]sodium[blank_end] channels by increasing inhibitory actions of [blank_start]GABA[blank_end] and regulating downstream signal transduction cascades. Also interacts with other ion channels e.g. voltage sensitive [blank_start]calcium[blank_end] channels, and indirectly blocks [blank_start]glutamate[blank_end]. 2. Carbamazepine Very good for acute [blank_start]mania[blank_end] and maintenance treatment, but is a potent [blank_start]CYP3A4[blank_end] inducer so generally 2nd/3rd line. MoA: Binds to [blank_start]alpha[blank_end] subunit of voltage-sensitive sodium channels and perhaps has additional effects at calcium and potassium ion channels, to enhance the [blank_start]inhibitory[blank_end] effects GABA. 3. Lamotrigine Useful for bipolar [blank_start]depression[blank_end] but unlicensed - increasingly popular. Similar effects to carbamazepine on sodium channels, blocks the α subunit. Also [blank_start]decreases[blank_end] glutamate release, which is unique. Comparatively [blank_start]well[blank_end] tolerated, excluding the propensity to cause [blank_start]rashes[blank_end] – minimize by [blank_start]slow[blank_end] dose increases. 4. Atypical antipsychotics For mania: Established for psychotic and nonpsychotic mania. In particular, [blank_start]quetiapine and aripiprazole[blank_end]. Antagonism or partial agonism of [blank_start]D2 hyperactivity[blank_end], and antagonism of [blank_start]5-HT2A[blank_end] receptors indirectly reduces [blank_start]glutamate hyperactivity[blank_end], may be MoA. For depression: Effects [blank_start]5HT2A, 5HT2C, & 5HT1A[blank_end] receptors - indirectly disinhibits [blank_start]NA and DA neurons[blank_end] theoretically improving mood and cognition. Mood improved by blocking NA and 5-HT reuptake. Adjunctive treatment options - [blank_start]benzodiazepines[blank_end] for agitation; topiramate or zonisamide for weight loss; and [blank_start]gabapentin or pregabalin[blank_end] for anxiety, sleep, or pain
Respuesta
  • TDM
  • 0.4–1.2 g
  • suicide
  • G
  • signal
  • 2nd messenger enzymes
  • downstream
  • manic
  • sodium
  • GABA
  • calcium
  • glutamate
  • mania
  • CYP3A4
  • alpha
  • inhibitory
  • depression
  • decreases
  • well
  • slow
  • rashes
  • quetiapine and aripiprazole
  • D2 hyperactivity
  • 5-HT2A
  • glutamate hyperactivity
  • 5HT2A, 5HT2C, & 5HT1A
  • NA and DA neurons
  • benzodiazepines
  • gabapentin or pregabalin

Pregunta 11

Pregunta
Match the unwanted effects to the drug: [blank_start]Lamotrigine[blank_end] - propensity to cause rashes [blank_start]Valproic acid[blank_end] - Weight gain, sedation [blank_start]Atypical antipsychotics[blank_end]: EPSEs, sedation, weight gain, sexual dysfunction, QT-prolongation [blank_start]Lithium[blank_end] - Weight gain, alopecia, tremor, sedation, nausea and decreased cognition, renal and thyroid function
Respuesta
  • Lamotrigine
  • Valproic acid
  • Atypical antipsychotics
  • Lithium
Mostrar resumen completo Ocultar resumen completo

Similar

Mental health chapter 10
nursing fairy
Mental State Exam
Matthew Coulson
Perinatal Psychiatry
Matthew Coulson
Psychiatry Genetics
Matthew Coulson
Eating Disorders
Matthew Coulson
Neurobiology of Addiction
Matthew Coulson
Addictive behaviour
Megan Kerr
Behavioral Neuroscience
Tambriell Caudill
Introduction to Psychology
Skye Chen
Liaison Psychiatry
Vishnu Pradeep
Perinatal Psychiatry
Kit Grissett